137 related articles for article (PubMed ID: 23810316)
1. Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms.
Loftis JM
Psychoneuroendocrinology; 2013 Sep; 38(9):1829-30. PubMed ID: 23810316
[No Abstract] [Full Text] [Related]
2. A response to the commentary "Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms" by Loftis, J.M. on "Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms" by Udina, M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R. http:\\dx.doi.org/10.1016/j.psyneuen.2013.03.007.
Udina M; Navinés R; Capuron L; Martín-Santos R
Psychoneuroendocrinology; 2013 Sep; 38(9):1830-1. PubMed ID: 23810434
[No Abstract] [Full Text] [Related]
3. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
Udina M; Moreno-España J; Navinés R; Giménez D; Langohr K; Gratacòs M; Capuron L; de la Torre R; Solà R; Martín-Santos R
Psychoneuroendocrinology; 2013 Sep; 38(9):1803-13. PubMed ID: 23571152
[TBL] [Abstract][Full Text] [Related]
4. Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.
Maddock C; Landau S; Barry K; Maulayah P; Hotopf M; Cleare AJ; Norris S; Pariante CM
Mol Psychiatry; 2005 Apr; 10(4):332-3. PubMed ID: 15655564
[No Abstract] [Full Text] [Related]
5. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
Bull SJ; Huezo-Diaz P; Binder EB; Cubells JF; Ranjith G; Maddock C; Miyazaki C; Alexander N; Hotopf M; Cleare AJ; Norris S; Cassidy E; Aitchison KJ; Miller AH; Pariante CM
Mol Psychiatry; 2009 Dec; 14(12):1095-104. PubMed ID: 18458677
[TBL] [Abstract][Full Text] [Related]
7. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
Wang LJ; Chen SW; Chen CK; Yen CL; Chang JJ; Lee TS; Liu CJ; Chen LW; Chien RN
BMC Psychiatry; 2016 Nov; 16(1):424. PubMed ID: 27884134
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.
Kraus MR; Schäfer A; Csef H; Scheurlen M
World J Gastroenterol; 2005 Mar; 11(12):1769-74. PubMed ID: 15793861
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.
Kraus MR; Al-Taie O; Schäfer A; Pfersdorff M; Lesch KP; Scheurlen M
Gastroenterology; 2007 Apr; 132(4):1279-86. PubMed ID: 17408646
[TBL] [Abstract][Full Text] [Related]
10. Acute life-threatening event with peginterferon α-2b in a child with chronic hepatitis C.
Bhat AS; Varma S; Chaturvedi MK
J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):e138. PubMed ID: 22847460
[No Abstract] [Full Text] [Related]
11. [Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].
Iwasaki Y; Ikeda F; Yamamoto K
Nihon Rinsho; 2011 May; 69 Suppl 4():215-20. PubMed ID: 22096922
[No Abstract] [Full Text] [Related]
12. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
Schäfer A; Scheurlen M; Seufert J; Keicher C; Weissbrich B; Rieger P; Kraus MR
J Hepatol; 2010 Jan; 52(1):10-5. PubMed ID: 19897271
[TBL] [Abstract][Full Text] [Related]
13. Managing the neuropsychiatric complications of hepatitis C treatment.
Sockalingam S; Shammi C; Stergiopoulos V
Br J Hosp Med (Lond); 2007 Oct; 68(10):520-5. PubMed ID: 17974293
[TBL] [Abstract][Full Text] [Related]
14. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
[TBL] [Abstract][Full Text] [Related]
15. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
[TBL] [Abstract][Full Text] [Related]
16. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ
Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
[No Abstract] [Full Text] [Related]
17. Black hairy tongue during interferon therapy for hepatitis C.
Arab JP; Vargas JI; Morales C; Arrese M
Ann Hepatol; 2015; 14(3):414-5. PubMed ID: 25864223
[No Abstract] [Full Text] [Related]
18. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
Papastergiou V; Skorda L; Lisgos P; Karatapanis S
Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
[No Abstract] [Full Text] [Related]
19. Mooren's ulcerative keratitis after systemic pegylated interferon alpha2a in chronic hepatitis C.
Yeo JH; Kim KW; Kim JC
Can J Ophthalmol; 2017 Oct; 52(5):e163-e167. PubMed ID: 28985822
[No Abstract] [Full Text] [Related]
20. Pegylated interferon associated lichen planus at the injection site.
Ergül B; Koçak E; Akbal E; Köklü S; Astarci HM
Acta Gastroenterol Belg; 2011 Dec; 74(4):591-2. PubMed ID: 22319976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
